| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.002 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.002 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |